DEXCOM, INC.

(DXCM)
  Report
Real-time Estimate Cboe BZX  -  05/17 02:42:07 pm EDT
330.33 USD   +1.76%
08:08aCitigroup Adjusts DexCom's Price Target to $525 From $630, Reiterates Buy Rating
MT
05/11TRANSCRIPT : DexCom, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 02:40 PM
CI
05/10Dexcom Announces Upcoming Conference Presentations
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about DEXCOM, INC.
08:08aCitigroup Adjusts DexCom's Price Target to $525 From $630, Reiterates Buy Rating
MT
05/11TRANSCRIPT : DexCom, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2..
CI
05/10Dexcom Announces Upcoming Conference Presentations
BU
04/29Raymond James Adjusts DexCom's Price Target to $486 From $538, Keeps Outperform Rating
MT
04/29Morgan Stanley Adjusts Price Target for DexCom to $492 From $514, Maintains Equalweigh..
MT
04/29SVB Leerink Adjusts DexCom's Price Target to $500 From $565, Keeps Outperform Rating
MT
04/29Piper Sandler Adjusts DexCom's Price Target to $480 From $725, Reiterates Overweight Ra..
MT
04/28DEXCOM : Reports First Quarter 2022 Financial Results - Form 8-K
PU
04/28TRANSCRIPT : DexCom, Inc., Q1 2022 Earnings Call, Apr 28, 2022
CI
04/28DEXCOM UPDATES FIRST QUARTER 2022 CO : 30 p.m. Eastern Time
BU
04/28DexCom's Q1 Earnings Down as Revenue Decreases
MT
04/28DEXCOM : Q1 Earnings Snapshot
AQ
04/28Earnings Flash (DXCM) DEXCOM Reports Q1 Revenue $628.8M, vs. Street Est of $624M
MT
04/28Earnings Flash (DXCM) DEXCOM Reports Q1 EPS $0.32, vs. Street Est of $0.52
MT
04/28Dexcom, Inc. Reiterates Earnings Guidance for the Full Year 2022
CI
04/28Dexcom Reports First Quarter 2022 Financial Results
BU
04/28DexCom, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/28EARNINGS REACTION HISTORY : DEXCOM INC, 87.5% Follow-Through Indicator, 8.6% Sensitive
MT
04/26DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More..
BU
04/26DexCom, Inc. Showcases Expanded CGM Portfolio at International ATTD Conference
CI
04/13INSIDER SELL : Dexcom
MT
04/07Dexcom Publishes Annual Sustainability Report
BU
04/07DEXCOM : G6 Continous Glucose Monitoring System Now Available Through Tricare Pharmacy Ben..
PU
04/01Equites Fall Midday as Parts of Yield Curve Turning Negative Undermine Sentiment
MT
04/01DexCom to Introduce Dexcom One in UK During May
MT
04/01Dexcom Announces Dexcom ONE, the Newest Real-Time Continuous Glucose Monitoring System,..
BU
04/01Dexcom Announces Dexcom ONE, the Newest Real-Time Continuous Glucose Monitoring System,..
CI
03/31DEXCOM SCHEDULES FIRST QUARTER 2022 : 30 p.m. Eastern Time
BU
03/31CAPITALGAINSREPORT : Healthcare Sector Offers Consistent Upside To Investors
AQ
03/25US Stocks Post Gains For Second Straight Week as Treasury Yields Surge Friday
MT
03/25Equities Under Pressure Midday as Yields Surge Amid Expectations for Aggressive Fed Rat..
MT
03/25DexCom Plans 4-to-1 Stock Split
MT
03/25Dexcom Announces Four-for-One Forward Stock Split
BU
03/24INSIDER SELL : Dexcom
MT
03/14SECTOR UPDATE : Health Care Advancing to Begin New Week
MT
03/14SECTOR UPDATE : Health Care
MT
03/14DexCom Secures Europe's CE Mark for G7 Continuous Glucose Monitoring System
MT
03/14Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System..
BU
03/07Ontario Announces Public Coverage for the Dexcom G6 Continuous Glucose Monitoring Syste..
BU
03/02BofA Securities Reinstates DexCom at Buy With $500 Price Target
MT
03/01FDA Grants Breakthrough Device Designation for Dexcom Hospital CGM System
BU
02/23TRANSCRIPT : DexCom, Inc. Presents at Citi’s 2022 Virtual Healthcare Conference, Feb-..
CI
02/16TRANSCRIPT : DexCom, Inc. Presents at 11th SVB Leerink Annual Global Healthcare Conference..
CI
02/16INSIDER SELL : Dexcom
MT
02/14Dexcom Announces Upcoming Virtual Conference Presentations
BU
02/11DEXCOM : Q4 Earnings Snapshot
AQ
02/11SECTOR UPDATE : Health Care Stocks Tumble Friday Afternoon
MT
02/11SECTOR UPDATE : Health Care Stocks Unable to Sustain Early Advance
MT
02/11Morgan Stanley Cuts Price Target on DexCom to $514 From $570, Maintains Equalweight Rat..
MT
02/10TRANSCRIPT : DexCom, Inc., Q4 2021 Earnings Call, Feb 10, 2022
CI
02/10DexCom Reports Lower Q4 Adjusted Earnings, Higher Revenue; Reiterates 2022 Sales Guidan..
MT
02/10DEXCOM : Reports Fourth Quarter and Fiscal Year 2021 Financial Results - Form 8-K
PU
02/10DexCom, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
02/10Earnings Flash (DXCM) DEXCOM Posts Q4 Revenue $698.2M, vs. Street Est of $698.7M
MT
02/10Dexcom Reports Fourth Quarter and Fiscal Year 2021 Financial Results
BU
02/10Earnings Flash (DXCM) DEXCOM Posts Q4 Revenue $698.2M, vs. Street Est of $698.7M
MT
02/10DexCom, Inc. Reiterates Earnings Guidance for the Fiscal Year 2022
CI
02/10DexCom, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
CI
02/10EARNINGS REACTION HISTORY : DEXCOM INC, 77.8% Follow-Through Indicator, 8.8% Sensitive
MT
02/04NORTH AMERICAN MORNING BRIEFING : Amazon.com, Snap -2-
DJ
02/03Dexcom G6 Continuous Glucose Monitoring System Now Covered in Alberta for Children and ..
BU
02/03BTIG Upgrades DexCom to Buy from Neutral, Sets $535 Price Target
MT
01/31Oppenheimer Adjusts DexCom's Price Target to $580 From $630, Maintains Outperform Ratin..
MT
01/31Exclusive-U.S. diabetes deaths top 100,000 for second straight year, federal panel urge..
RE
01/28Health Care Stocks Still Advancing Ahead of Friday Close
MT
01/28Health Care Stocks Posting Modest Gains
MT
01/28Insulet Shares Rally on FDA Approval of Omnipod 5
DJ
01/28Insulet Gets FDA OK for Omnipod 5 Automated Insulin-Delivery System
DJ
01/28Insulet Secures FDA Clearance for its Omnipod 5 Automated Insulin Delivery System
MT
01/24DEXCOM SCHEDULES FOURTH QUARTER AND : 30 p.m. Eastern Time.
BU
01/21INSIDER SELL : Dexcom
MT
01/19DexCom Shares Rise After Wells Fargo Upgrade
MT
01/19Raymond James Adjusts DexCom's Price Target to $538 from $618, Keeps Outperform Rating
MT
01/19Wells Fargo Upgrades DexCom to Overweight From Equalweight; Price Target is $575
MT
01/11UBS Adjusts DexCom Price Target to $640 From $660, Maintains Buy Rating
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on DEXCOM, INC.